LNSR
LENSAR Inc (LNSR)
Healthcare • NASDAQ • $5.77-0.60%
- Symbol
- LNSR
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $5.77
- Daily Change
- -0.60%
- Market Cap
- $71.26M
- Trailing P/E
- 32.22
- Forward P/E
- -11.37
- 52W High
- $12.94
- 52W Low
- $4.95
- Analyst Target
- $11.33
- Dividend Yield
- 0.00%
- Beta
- 0.95
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Flori…
Company websiteResearch LNSR on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.